Skip to main content
Lawrence Tiglao, MD, Obstetrics & Gynecology, Fremont, CA, Washington Hospital Healthcare System

LawrenceMatthewTiglaoMD

Obstetrics & Gynecology • Fremont, CA

Hospitalist

OB Hospitalist Medical Director

Join to view full profile

Dr. Tiglao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tiglao's full profile

Already have an account?

Education & Training

  • University of California Davis Health
    University of California Davis HealthResidency, Obstetrics and Gynecology, 2010 - 2014
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 2010
  • University of California at Los Angeles
    University of California at Los AngelesB.S., Anthropology, Cum Laude, 2003 - 2006

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2024 - 2025
  • CA State Medical License
    CA State Medical License 2011 - 2025
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

  • Special Resident in Minimally Invasive Gynecology Award CDMCAAGL, 2014
  • Most Valuable Student Award UCLA Stroke Study Program, 2004
  • Participant San Francisco General Hospital PVP program, 2004
  • Join now to see all

Publications & Presentations

Abstracts/Posters

  • Tumor-specific targeting with novel LXY-30 peptide linked nanoparticles for paclitaxel delivery in ovarian cancer mouse xenograft model.
    Suby, N., Xiao K., Yi, Y., Tiglao, L.M., Lam, K., SGO Annual Meeting, 1/1/2013
  • Incidence of Venous Thrombo-Embolism After Robotic Assisted Total Laparoscopic Hysterectomy for Endometrial Cancer.
    Suby N, Tiglao L.M., Leiserowitz G., WAGO Annual Meeting, 1/1/2012

Lectures

  • "Risk of invasive adenocarcinoma of the cervix following treatment of adenocarcinoma in situ (AIS): Can cotesting identify a group for which subsequent hysterectomy is... 
    5/1/2013

Press Mentions

  • MarinHealth Receives Quality and Sustainability Award for Achieving Low Cesarean Birth Rate
    MarinHealth Receives Quality and Sustainability Award for Achieving Low Cesarean Birth RateJune 15th, 2022

Hospital Affiliations

Dr. Lawrence Tiglao, Dr. Lawrence Tiglao, MD, Dr. L Tiglao, Dr. Lawrence Matthew Tiglao